“Curcumin for Aromatase Inhibitor-Induced Joint Pain in Breast Cancer Survivors - The CurPain Trial: A Randomized, Double-Blind, Phase III, Multicenter Clinical Trial”, PPCR, vol. 9, no. 2, Sep. 2023, doi: 10.21801/ppcrj.2023.92.10.